China's Luye Pharma seeks up to $761 mln in HK relisting-Reuters
Three Chinese private funds are seeking up to HK$5.9 billion ($761.14 million) for the Hong Kong initial public offering of China's Luye Pharma Group Ltd, a source with direct knowledge of the matter told Reuters on Monday.
23 June 2014•1 min read
